Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
Background Use of a polysaccharide vaccine challenge to demonstrate immunologic memory after priming with capsular group C meningococcal conjugate vaccines (MenCC) risks induction of immunologic hyporesponsiveness. For this reason, MenCC vaccines are now used as probes of immunologic memory, however...
Main Authors: | Pace, D, Khatami, A, Attard-Montalto, S, Voysey, M, Finn, A, Faust, S, Heath, P, Borrow, R, Snape, M, Pollard, A |
---|---|
Format: | Journal article |
Published: |
Elsevier
2016
|
Similar Items
-
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
by: Pace, D, et al.
Published: (2015) -
Will booster doses be required for serogroup B meningococcal vaccine?
by: McQuaid, F, et al.
Published: (2014) -
Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
by: Khatami, A, et al.
Published: (2011) -
Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules
by: Sadarangani, M, et al.
Published: (2017) -
ANTIBODY RESPONSE TO BOOSTER DOSES OF HEPATITIS B VACCINE IN MEDICAL STUDENTS VACCINATED IN INFANCY
by: R. Mohd Noh, et al.
Published: (2023-08-01)